Business Context and Reporting Period
Company: ENI S.p.A.
Filing Type: Form 6-K (Interim Consolidated Report)
Reporting Period: First half ended June 30, 2023
Filing Date: August 4, 2023
Eni reported results for the first half of 2023 in a challenging commodity price environment. Brent crude oil prices averaged $80/bbl (down 26% from H1 2022), and European gas prices (PSV) averaged €500/kcm (down 52% from H1 2022). Despite this, the Group maintained robust operational performance and cash generation.
Key Financial Metrics
| Metric (€ million) | H1 2023 | H1 2022 | Change |
|---|---|---|---|
| Sales from operations | 46,776 | 63,685 | -26.6% |
| Operating profit | 4,275 | 11,322 | -62.2% |
| Adjusted operating profit | 8,022 | 11,032 | -27.3% |
| Net profit (attributable to shareholders) | 2,682 | 7,398 | -63.7% |
| Adjusted net profit | 4,842 | 7,078 | -31.6% |
| Net cash flow from operating activities | 7,425 | 7,281 | +2.0% |
| Capital expenditure | 4,676 | 3,193 | +46.4% |
| Net borrowings (ex IFRS 16) | 8,215 | 7,872 | +4.4% |
| Leverage (ex IFRS 16) | 0.15 | 0.15 | - |
Material Changes vs. Prior Period
- Exploration & Production (E&P): Adjusted operating profit decreased 48% to €4.9 billion due to lower realized prices and the deconsolidation of former Angolan subsidiaries (now equity-accounted in Azule Energy). Hydrocarbon production increased 1% to 1.63 million boe/d.
- Global Gas & LNG Portfolio (GGP): Adjusted operating profit surged to €2.5 billion (from €0.9 billion in H1 2022), driven by contractual triggers, renegotiations, and asset optimization despite lower gas volumes sold (-18%).
- Sustainable Mobility, Refining and Chemicals: Adjusted operating profit fell to €0.4 billion (from €1.0 billion) due to lower refining margins not fully captured by benchmarks and a €0.2 billion loss in the Chemicals segment caused by weak demand.
- Plenitude & Power: Adjusted operating profit rose 8% to €0.4 billion, supported by renewable capacity ramp-up and retail business performance.
- Balance Sheet: Net borrowings increased to €8.2 billion, but leverage remained stable at 0.15, within the target range of 0.1–0.2.
Guidance, Outlook, and Risks
Updated 2023 Guidance
- Group Adjusted EBIT: Confirmed at €12 billion (underlying raise of ~€2 billion) despite a lowered price scenario (Brent $80/bbl).
- Capex: Lowered to under €9.0 billion (from €9.2 billion).
- Dividends: Full year 2023 dividend of €0.94 per share approved. First tranche of €0.24/share payable September 20, 2023.
- Share Buyback: Program of up to €3.5 billion authorized; €635 million spent on 48 million shares through July 28, 2023.
Key Risks and Contingencies
- Commodity Prices: Continued volatility in oil and gas prices remains the primary driver of financial performance.
- Geopolitics: Risks associated with the Russia-Ukraine conflict, including supply chain disruptions and sanctions. Eni has reduced dependence on Russian gas to zero.
- Climate Change: Regulatory risks regarding carbon taxes and potential litigation related to climate change liability.
- Country Risk: Operational risks in non-OECD countries, specifically Venezuela (recoverability of receivables) and Nigeria (overdue receivables from state partners).
Investor Verification Checklist
- Adjusted vs. Reported Profit: Verify the reconciliation between reported net profit (€2.7 billion) and adjusted net profit (€4.8 billion) to understand the impact of special items and inventory holding gains/losses.
- Angola Deconsolidation: Confirm the impact of moving Angolan assets to equity-accounted status (Azule Energy) on future revenue recognition and cash flow visibility.
- Chemicals Segment Loss: Assess the sustainability of the Chemicals segment's loss (€0.2 billion) given the stated "exceptionally low demand" and competitive pressures.
- Capex Execution: Monitor the ability to reduce full-year Capex to under €9.0 billion while maintaining production growth targets.
- Dividend Coverage: Verify that organic free cash flow (€3 billion in H1) is sufficient to cover the full-year dividend obligation and buyback program.